Frank J. Lanza serves as Executive at Harpoon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Frank J. Lanza has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 11, 2024 involved selling 18,734 shares valued at $0.
Frank J. Lanza currently holds 18,362 shares of Harpoon Therapeutics, Inc. (HARP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank J. Lanza has been a net neutral trader of HARP stock. They have purchased $0 and sold $0 worth of shares.
Frank J. Lanza's most recent insider trade was on Mar 11, 2024, when they sold 18,734 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 26, 2023 | HARP | $0 | Award | 2,000 | $N/A | Discretionary |